For citations:

Volodin A.A., Maximov M.L., Slobodyan V.G., Alyautdin R.N. SGLT2 inhibitors: control of glycemia and nephroprotection properties. Safety and Risk of Pharmacotherapy. 2017;5(1):11-26. (In Russ.)